Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

O'Key's Q1 revenue grew by 2.6%

4/30/25 OKEY

Lambumiz reported for 2024 by IFRS

4/30/25 LMBZ

Board of Directors of Acron recommended that dividends be paid for 2024

4/30/25 AKRN

Board of Directors of Acron recommended that dividends be paid for 2024

4/30/25 AKRN

UTair Aviation reported for 3 months of 2025 by RAS

4/30/25 UTAR

KuibyshevAzot reported for 3 months of 2025 by RAS

4/30/25 KAZT

Magnit buys a controlling stake in Azbuka Vkusa

4/30/25 MGNT

Sovcombank reported for 2024 by RAS

4/29/25 SVCB

MMK-METIZ reported for 2024 by IFRS

4/29/25 MMMZ

PIK reported for 3 months of 2025 by RAS

4/29/25 PIKK